Abstract:Background: Gram-negative bacilli are one of the most common causes of various infections in clinical. The emergence and global spread of multi-drug resistant gram-negative bacilli has become a major challenge in the global public health field. Methods: A total of 51,189 non-repetitive strains of gram-negative bacilli were isolated in clinical settings. The antimicrobial susceptibility testing was conducted by using the automated VITEK 2 compact system and the matched AST susceptibility test card, complemented by the disk diffusion method. The antimicrobial susceptibility results were interpreted by CLSI. Rates of MDR and XDR in Klebsiella pneumoniae , Acinetobacter baumannii , and Pseudomonas aeruginosa were investigated. Used the chi-square test to determine whether the antimicrobial resistance rates of four major gram-negative bacilli isolated from ICU and non-ICU department have statistical differences. Results: Escherichia coli (31.4%), Klebsiella spp. (21.2%), Acinetobacter spp. (13.8%), and P. aeruginosa (11.0%) were the most frequently isolated gram-negative bacilli. Escherichia coli was the top one organism isolated from urinary tract (68.4%), bloodstream (39.9%), body fluid (33.2%), wound and pus (37%), except for respiratory tract (8.8%). Whereas Acinetobacter baumannii and K. pneumoniae were the major isolated organisms from respiratory tract. Acinetobacter baumannii showed high resistance to fluoroquinolones, β-lactam/β-lactamase inhibitor combinations class, ceftazidime, cefepime, imipenem, and meropenem, the resistance rates reached more than 70%. Ceftazidime showed a lower resistance rate to E. coli than ceftriaxone. For E. coli , fluoroquinolones showed a high resistance rate (ciprofloxacin 61.36% and levofloxacin 53.97%), whereas amikacin, carbapenems exhibited a lower resistance rate fluctuating at 2%. Acinetobacter baumannii and K. pneumoniae showed rapid increases in carbapenem resistance whereas E. coli had the lowest resistance rate and remain stable at 2%. Acinetobacter baumannii exhibited the highest rate of MDR and XDR, reaching 60–80 and 45–55%, respectively. Compared to non-ICU departments, the resistance rates of four major gram-negative bacilli in the ICU department were much higher and the differences were statistically significant ( p < 0.05). Conclusion: Amikacin, carbapenems, and piperacillin/tazobactam exhibited relatively high sensitivity, whereas fluoroquinolones showed high resistance rate whether they can be the first-line antimicrobials for empirical treatment of UTI should take more consideration. The gram-negative bacilli in ICU were more resistance than that in non-ICU. These findings are helpful for clinicians using antimicrobials reasonably.

Clinical distribution and antimicrobial resistance spectrum analysis of Klebsiella pneumoniae strains isolated from patients of ICU, NSICU, CCU and RICU in a comprehensive hospital

Mohnarin Report of 2011: Monitoring of Bcterial Resistance Intensive Care Unit

Mohnarin Report of 2010:Monitoring of Bacterial Resistance in Intensive Care Units

The clinical distribution and drug-resistance of pathogens of lower respiratory infection in intensive care units

Mohnarin report of 2011:monitoring of bacterial resistance of non-ICU inpatients

Distribution of Pathogenic Bacteria Causing Nosocomial Infections in ICU and Drug Resistance Analysis

Mohnarin Report of 2010 :Surveillance of Bacterial Resistance of Non-Icu Inpatients

Distribution and antimicrobial resistance of maj or gram-negative bacilli in ICU and non-ICU wards in a grass-roots hospital

Distribution of pathogenic bacteria of hospital acquired infections in intensive care unit and its drug-resistances

Analysis on 319 strains pathogenic bacteria distribution and antimicrobial drug sensitive rate in ICU

Distribution and antimicrobial resistance profiles of 1830 isolates of Klebsiella pneumoniae from 2013 to 2015

Surveillance of antimicrobial resistance among clinical isolates from intensive care units in tertiary hospital, 2012

Pathogen Distribution in ICU with Respiratory Tract Infection and Analysis of Drug Resistance

Distribution and antimicrobial resistance analysis of gram-negative bacilli isolated from a tertiary hospital in Central China: a 10-year retrospective study from 2012 to 2021

Analysis on Distribution and Antibacterial Resistance of Nosocomial Infection Pathogens of ICU Inpatients in a Hospital

Changes of Pathogens and Antimicrobial Resistance of Nonfermenting Gram-negative Bacilli in Intensive Care Unit

Distribution and change in antimicrobial resistance of bacteria from sputum of patients in respiratory intensive care unit

Analysis of drug resistance of Pseudomonas aeruginosa isolated from Intensive Care Unit, Respire Intensive Care Unit, Nerve Surgery Intensive Care Unit, Emergency Intensive Care Unit

Susceptibility of Pathogens Isolated from Intensive Care Unit

Respiratory intensive care unit of pathogens of respiratory tract infection distribution and drug resistance analysis

Mohnarin Annual Report 2010 :Surveillance of Antimicrobial Resistance in Bacteria Isolated from Intensive Care Units